skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Navigating the issues presented by biosimilars is becoming more complicated. With new barriers facing biosimilar originator companies and threatening to derail development, knowing how to formulate and manage your own biosimilar action plan is critically important.

Explore the components essential for understanding how biosimilar originator companies are responding to threats to their profit margins with this webinar recording from Informa Pharma Intelligence.

Experts from Scrip, part of the Informa Pharma Intelligence suite of tools, used data from across Pharma Intelligence to present vital information about the issues facing the biosimilars market and what they might mean for the future.

Listen to the recording now, where Scrip experts will be:

  • Analyzing the exposure of key originator companies to biosimilar competition
  • Considering the different tactics that originators are using in the face of biosimilar competition
  • Examining the situation across global markets, including the regulatory environments
  • Reviewing the first Humira biosimilars to launch in Europe
  • Exploring how the first US biosimilars are trending and the challenging commercial dynamics
  • Providing insights into likely future developments and trends

    The slides are available to download here

    Read also

    • In Vivo: strategic insights for life sciences decision-maker...

      Pharma News and Healthcare Business Insights

      Pharma Intelligence offers a wealth of pharmaceutical industry news and strategic insight into the healthcare & biotechnology markets from around the world. Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

    • Medtech Insight: global medical technology news & analysis

      UK Notified Body BSI Sets Out Clear Post-Brexit Paths As It Goes Dutch

      BSI tackles Brexit issues head-on with aim to allay fears and bring clarity while UK regulator, MHRA, remains reticent to do so. Its messages are relevant for all doing business in the UK

      Topics Brexit

    • Scrip: industry news and insights

      Exploring Sanofi's Revamped IO Pipeline

      ByLucie Ellis

      In an exclusive interview, Sanofi's head of oncology development Joanne Lager explains how the French big pharma could make a comeback in cancer this year and highlights its immunotherapy combination opportunities.

      Topics Cancer


    Next steps

    Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

    Request live demo now:

    Our team is always happy to hear from you. Please call us at:

    • US Toll-Free  : +1 888 670 8900
    • US Toll           : +1 908 547 2200
    • UK & Europe : +44 (20) 337 73737
    • Australia        : +61 2 8705 6907
    • Japan              : +81 3 6273 4260

    Or please submit your inquiry via the form so that we can provide you the best possible customer service.

    Have an immediate and specific information need?

    Browse and buy from 1000s of analysis and research reports now: